USFDA may have dropped standards too far in hunt for Covid-19 drug: Report

Although some rules can be waived in an emergency, the FDA dropped its quality-control standards too far as it scoured the world for scarce supplies of chloroquine drugs.

After US President Donald Trump touted chloroquine drugs as a "gamechanger" in the fight against Covid-19 and the government moved towards build an emergency stockpile of the drug - Bayer AG donated three million tablets of the drug called Resochin

According to Reuters, the administration officials privately described this as what they felt was a "win" in the president's efforts to build the emergency stockpile.

However, in an exchange of enthusiastic emails among federal health officials reviewed by Reuters, Keagan Lenihan, chief of staff of the US Food and Drug Administration (FDA), cautioned that "3-4 days" of testing would be needed.